Last reviewed: June 5, 2026
Last updated: June 5, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Ozempic (semaglutide) has become one of the most prescribed medications for weight loss, with clinical trials showing average weight loss of 15 pounds over 68 weeks. However, both brand-name Ozempic and generic semaglutide come with a documented list of potential side effects that range from temporary gastrointestinal upset to rare but serious complications. Understanding these risks—and which ones apply to your biology—helps you make an informed decision about whether GLP-1 therapy is right for you.
Common Side Effects of Ozempic and Semaglutide Injections
The most frequently reported side effects of semaglutide affect the digestive system. Nausea occurs in approximately 25–40% of patients during the first few weeks of treatment, while vomiting, constipation, and diarrhea each affect 10–20% of users. Most patients find these symptoms subside within 2–4 weeks as their body adjusts to the medication. Starting at a low dose and increasing gradually—a strategy called titration—significantly reduces the severity of gastrointestinal upset.
Beyond stomach and intestinal complaints, some patients experience appetite loss so pronounced that eating becomes a deliberate task rather than an automatic behavior. Headaches, fatigue, and dizziness have been reported in smaller percentages of the patient population. These symptoms are typically mild to moderate and improve as treatment continues. PlexusDx compounds semaglutide at starting doses as low as 0.25 mg, allowing your provider to introduce the medication gently into your system.
Serious and Rare Semaglutide Side Effects You Should Know About
While uncommon, semaglutide carries warnings for several serious conditions that require immediate medical attention. Acute pancreatitis—inflammation of the pancreas—has been documented in post-market surveillance reports, though the true incidence rate remains difficult to establish. Thyroid tumors were observed in animal studies at doses much higher than those used in humans, leading to a black-box warning against use in patients with a personal or family history of medullary thyroid cancer. Retinal complications have also been reported in patients with existing diabetic retinopathy.
Gallbladder problems, including gallstones and cholecystitis, occur more frequently in GLP-1 users than in the general population, possibly due to rapid weight loss and changes in bile composition. Dehydration is another serious concern, particularly in patients who experience persistent vomiting or diarrhea and do not maintain adequate fluid intake. Some patients have reported cases of acute kidney injury, though most recovered after stopping the medication. A frank discussion with your healthcare provider about your medical history helps identify whether any of these rare risks apply to you.
How Genetic Testing Reveals Your Personal Risk Profile
Not every patient experiences side effects at the same rate or severity. PlexusDx Precision Peptide Genetic Test examines 14 metabolic pathways and 49 peptides to map your individual response to semaglutide and other GLP-1 compounds. Variants in genes like GLP1R rs6923761 influence how efficiently your body binds and responds to the medication, meaning some patients require lower doses to achieve results while others tolerate higher amounts comfortably. Testing costs $99 as an add-on after your first month of treatment, giving your provider science-backed insight into whether you're genetically predisposed to side effects.
The FTO rs9939609 variant, associated with appetite regulation and metabolic rate, may predict how aggressively your hunger signals diminish on GLP-1 therapy. MC4R rs17782313 affects melanocortin signaling, another pathway central to weight control and satiety. By identifying these patterns early, PlexusDx helps you and your provider fine-tune your dose before side effects become problematic. This personalized approach reflects the shift toward precision medicine, where treatment matches biology rather than a one-size-fits-all protocol.
PlexusDx Compounded Semaglutide: Lower Starting Dose, Better Tolerability
PlexusDx partners with licensed 503A compounding pharmacies—not 503B facilities—to prepare semaglutide specifically tailored to your treatment plan. Compounded semaglutide starts at $149 per month flat, and your dose can increase without increasing your cost. Unlike Ozempic, which comes in preset pen strengths, compounded semaglutide allows your provider to start you at micro-doses (as low as 0.1 mg or 0.15 mg) and adjust in increments that match your tolerance. This precision dramatically reduces the likelihood of early discontinuation due to side effects.
PlexusDx serves all 50 states without requiring insurance or a membership fee, and HSA/FSA accounts cover the full cost. Your compounded medication ships directly to your home with clear instructions on injection technique and side effect management. If nausea or other GI symptoms emerge, your provider can pause dose escalation, hold you at your current level longer, or switch to oral semaglutide ($249/mo) if injections aren't working for you. This flexibility is a major advantage of compounded therapy over brand-name alternatives, which offer limited dose options.
What to Do If You Experience Serious Side Effects
If you develop sudden severe abdominal pain, persistent vomiting, rapid heartbeat, difficulty breathing, or signs of severe allergic reaction while taking semaglutide, stop the medication immediately and seek emergency care. These symptoms demand urgent medical evaluation, even though the risk of life-threatening complications remains low. Notify your PlexusDx provider as soon as possible so your medical record is updated and an alternative treatment path can be discussed.
For milder but bothersome side effects like ongoing nausea or constipation, communicate with your provider before your next dose. Practical strategies include eating smaller, blander meals, staying hydrated, and using over-the-counter anti-nausea or stool-softening medications as appropriate. Many patients find that consistent physical activity and dietary adjustments reduce side effect severity. PlexusDx providers are trained to distinguish between temporary adjustment effects and genuine intolerance, helping you stay on treatment or pivot to a better option like tirzepatide or oral formulations.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Is Ozempic safer than compounded semaglutide from PlexusDx?
Both Ozempic and compounded semaglutide contain the same active ingredient and carry the same FDA safety warnings. The key difference is dosing flexibility: PlexusDx compounds allow your provider to start at lower doses and increase gradually, reducing early side effects.
Can the Precision Peptide Genetic Test predict which side effects I'll experience?
The Precision Peptide Genetic Test ($99) examines 14 pathways and 49 peptides to reveal your genetic predisposition to GLP-1 response and metabolism.
How long do nausea and other GI side effects last?
Most gastrointestinal side effects (nausea, vomiting, constipation) peak within 1–2 weeks of starting or increasing a dose, then improve significantly over the next 2–4 weeks. Gradual dose escalation—a benefit of compounded medications from PlexusDx—stretches this adjustment window and reduces symptom severity.
What is the risk of pancreatitis from semaglutide?
Acute pancreatitis is a documented but rare side effect of GLP-1 medications. While exact incidence rates are unclear, it remains a genuine concern for patients with a history of gallstones, high triglycerides, or previous pancreatic disease. Anyone with risk factors should discuss this openly with their provider before starting treatment.
Does PlexusDx offer alternatives if semaglutide causes too many side effects?
Yes. If injected semaglutide triggers intolerable side effects, PlexusDx offers oral semaglutide ($249/mo), compounded tirzepatide injection ($249/mo), oral tirzepatide ($279/mo), and the GLP-Squared dual-compound option. Your provider can also recommend the microdose GLP-1 protocol ($129/mo) if you need a gentler starting point.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Does Ozempic Work on the First Day? Setting Realistic Expectations for Your Weight Loss Journey
How Soon Do Side Effects Start with Semaglutide? Understanding the Timeline